ID

11706

Beskrivning

The purpose of this study is to test the hypothesis that the onset of the antiplatelet effect of ticagrelor is more rapid and greater than clopidogrel in Chinese patients with ACS.

Nyckelord

  1. 2015-07-28 2015-07-28 -
  2. 2015-11-21 2015-11-21 -
Uppladdad den

28 juli 2015

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0 Legacy

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :


Inga kommentarer

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Criteria: A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS (HouYi)

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion Criteria
Beskrivning

Inclusion Criteria

Provision of informed consent prior to any study specific procedures
Beskrivning

Provision of informed consent prior to any study specific procedures

Datatyp

boolean

Alias
UMLS CUI-1
C0021430
Female or male
Beskrivning

Female or male

Datatyp

boolean

Alias
UMLS CUI-1
C0079399
Aged at least 18 years
Beskrivning

Aged at least 18 years

Datatyp

boolean

Alias
UMLS CUI-1
C0001779
Females of child-bearing potential must have a negative urine pregnancy test at enrolment
Beskrivning

Females of child-bearing potential must have a negative urine pregnancy test at enrolment

Datatyp

boolean

Alias
UMLS CUI-1
C0549206
Females of child-bearing potential must be willing to use reliable contraception
Beskrivning

Females of child-bearing potential must be willing to use reliable contraception

Datatyp

boolean

Alias
UMLS CUI-1
C0009871
Index event of non-ST or ST segment elevation ACS.
Beskrivning

Index event of non-ST or ST segment elevation ACS.

Datatyp

boolean

Exclusion Criteria
Beskrivning

Exclusion Criteria

Contraindication or other reason that clopidogrel should not be administered
Beskrivning

Contraindication or other reason that clopidogrel should not be administered

Datatyp

boolean

Alias
UMLS CUI-1
C1319916
Contraindication or other reason that ticagrelor should not be administered
Beskrivning

Contraindication or other reason that ticagrelor should not be administered

Datatyp

boolean

Alias
UMLS CUI-1
C1999375
UMLS CUI-2
C0522473
Oral anticoagulation therapy within 30 days prior to randomisation or cannot be stopped
Beskrivning

Oral anticoagulation therapy

Datatyp

boolean

Alias
UMLS CUI-1
C0354604
GP IIb/IIIa receptor antagonists therapy within 30 days prior to randomisation or cannot be stopped
Beskrivning

GP IIb/IIIa receptor antagonists therapy within 30 days prior to randomisation or cannot be stopped

Datatyp

boolean

Alias
UMLS CUI-1
C3640054
Ticagrelor within 14 days prior to randomisation
Beskrivning

Ticagrelor within 14 days prior to randomisation

Datatyp

boolean

Alias
UMLS CUI-1
C1999375
Clopidogrel within 14 days prior to randomisation
Beskrivning

Clopidogrel or other P2Y12 inhibitors within 14 days prior to randomisation

Datatyp

boolean

Alias
UMLS CUI-1
C0070166
P2Y12 inhibitors within 14 days prior to randomisation
Beskrivning

P2Y12 inhibitors within 14 days prior to randomisation

Datatyp

boolean

Alias
UMLS CUI-1
C2936588
Requires dialysis
Beskrivning

Requires dialysis

Datatyp

boolean

Alias
UMLS CUI-1
C0019004
Nonselective non-steroidal anti-inflammatory drugs therapy that cannot be stopped
Beskrivning

Nonselective non-steroidal anti-inflammatory drugs therapy that cannot be stopped

Datatyp

boolean

Alias
UMLS CUI-1
C0003211
prostacyclins (PGI2) therapy that cannot be stopped
Beskrivning

prostacyclins (PGI2) therapy that cannot be stopped

Datatyp

boolean

Alias
UMLS CUI-1
C2825061

Similar models

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Inclusion Criteria
Informed consent
Item
Provision of informed consent prior to any study specific procedures
boolean
C0021430 (UMLS CUI-1)
Gender
Item
Female or male
boolean
C0079399 (UMLS CUI-1)
Age
Item
Aged at least 18 years
boolean
C0001779 (UMLS CUI-1)
Pregnancy
Item
Females of child-bearing potential must have a negative urine pregnancy test at enrolment
boolean
C0549206 (UMLS CUI-1)
Contraceptive
Item
Females of child-bearing potential must be willing to use reliable contraception
boolean
C0009871 (UMLS CUI-1)
Acute coronary syndrome
Item
Index event of non-ST or ST segment elevation ACS.
boolean
Item Group
Exclusion Criteria
Clopidogrel contraindicated
Item
Contraindication or other reason that clopidogrel should not be administered
boolean
C1319916 (UMLS CUI-1)
Ticagrelor contraindicated
Item
Contraindication or other reason that ticagrelor should not be administered
boolean
C1999375 (UMLS CUI-1)
C0522473 (UMLS CUI-2)
Oral anticoagulants
Item
Oral anticoagulation therapy within 30 days prior to randomisation or cannot be stopped
boolean
C0354604 (UMLS CUI-1)
GPIIb/IIIa receptor antagonist
Item
GP IIb/IIIa receptor antagonists therapy within 30 days prior to randomisation or cannot be stopped
boolean
C3640054 (UMLS CUI-1)
Ticagrelor
Item
Ticagrelor within 14 days prior to randomisation
boolean
C1999375 (UMLS CUI-1)
Clopidogrel
Item
Clopidogrel within 14 days prior to randomisation
boolean
C0070166 (UMLS CUI-1)
Thienopyridines
Item
P2Y12 inhibitors within 14 days prior to randomisation
boolean
C2936588 (UMLS CUI-1)
Hemodialysis
Item
Requires dialysis
boolean
C0019004 (UMLS CUI-1)
NSAID
Item
Nonselective non-steroidal anti-inflammatory drugs therapy that cannot be stopped
boolean
C0003211 (UMLS CUI-1)
Prostacycline
Item
prostacyclins (PGI2) therapy that cannot be stopped
boolean
C2825061 (UMLS CUI-1)

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial